Is a complete ETR/HPHA research report available?

No complete published report is available for etr/HPHA (ETR/HPHA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/HPHA (ETR/HPHA)

Deutsche Börse Xetra: ETR/HPHA · EUR

€2.50

+0.05 (+2.0%)· Recorded snapshot

Market cap	117M
Revenue (ttm)	7.4M
Net income (ttm)	-33.1M
EPS (ttm)	-€0.71
Shares out	46.8M
Volume	958
Beta	0.77

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.4M
Net income (ttm): -33.1M
EPS (ttm): -€0.71
Market cap: 117M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-12 02:00 UTC

All ETR/HPHA indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

EUR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	41
Employees Change	-73%
Employees Change Percent	-64.04
Enterprise value	EUR 92.1M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	DE000A11QVV0
Last refreshed	2026-09-12
Market cap	EUR 117M
Price	EUR 2.5
Price currency	EUR
Rev Per Employee	181,590.46x
Sector	Healthcare
Sector PE	37.54
Sector PE Fwd	14.15
Sic	2836
Symbol	etr/HPHA
Website	https://heidelberg-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.3%
EV/Sales	12.37x
FCF yield	-21.26%
P/B ratio	-8.23x
P/S ratio	15.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	87.49%
Gross Profit	EUR 6.5M
Gross Profit Growth	77.84%
Gross Profit Growth Q	5,788.61%
Gross Profit Growth3 Y	-1.57%
Gross Profit Growth5 Y	31.98%
Net Income	EUR -33.1M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-424.8%
Profit Per Employee	EUR -807,385
Profitable Quarters	EUR 1
ROA	-42.58
Roa5y	-39.93
ROCE	-93.75
ROE	-1,539.9
Roe5y	-165.6
ROIC	-1,042.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.73%
Cagr15y	-10.84%
Cagr1y	-29.59%
Cagr3y	-9.56%
Cagr5y	-18.14%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	77.97x
Revenue Growth Q	3,566.19x
Revenue Growth Qo Q	43.31x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.12x
Revenue Growth5 Y	2.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.14
Assets	EUR 46.9M
Cash	EUR 24.9M
Current Assets	EUR 37.8M
Current Liabilities	EUR 7.2M
Debt	EUR 45,985
Debt FCF	EUR -0
Equity	EUR -14.2M
Interest Coverage	-11,718.3
Liabilities	EUR 61.1M
Long Term Assets	EUR 9.1M
Long Term Liabilities	EUR 54M
Net Cash	EUR 24.9M
Net Cash By Market Cap	EUR 21.28
Net Cash Growth	-24.89%
Tangible Book Value	EUR -23M
Tangible Book Value Per Share	EUR -0.49
WACC	8.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.29
Inventory Turnover	0.08
Net Working Capital	EUR 5.7M
Quick ratio	3.78
Working Capital	EUR 30.7M
Working Capital Turnover	EUR 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	58.71%
1Y total return	-29.58%
200-day SMA	2.76
3Y total return	-26.04%
50-day SMA	2.54
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.24%
All Time High	61.16
All Time High Change	-95.91%
All Time High Date	2007-02-06
All Time Low	1.39
All Time Low Change	80.25%
All Time Low Date	2016-08-25
ATR	0.11
Beta	0.77
Beta1y	-0.14
Beta2y	0.4
Ch YTD	0.81
High	2.5
High52	3.69
High52 Date	2025-09-12
High52ch	-32.25%
Low	2.4
Low52	2.33
Low52 Date	2025-12-29
Low52ch	7.3%
Ma50ch	-1.69%
Price vs 200-day SMA	-9.45%
RSI	48.41
RSI Monthly	41.86
RSI Weekly	42.56
Sharpe ratio	-0.75x
Sharpe Ratio3y	-0.12x
Sharpe Ratio5y	-0.19x
Sortino ratio	-0.92
Sortino Ratio3y	-0.04
Sortino Ratio5y	-0.17
Total Return	-0.33%
Tr YTD	0.81
Tr15y	-82.12%
Tr1w	-1.19%
Tr3m	-3.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,966,385%
Net Borrowing	-123,164
Shares Insiders	2.31%
Shares Institutions	0.73%
Shares Out	46,784,317
Shares Qo Q	-3.03%
Shares Yo Y	0.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -24.8M
Adjusted OCF	-24,778,985
Average Volume	2,010.85x
Bv Per Share	-0.3
CAPEX	EUR -62,894
Ch10y	58.53
Ch15y	-82.42
Ch1w	-1.19
Ch1y	-29.58
Ch3m	-3.85
Ch3y	-26.04
Ch5y	-63.24
Ch6m	-18.03
Change	2.04%
Change From Open	4.17
Close	2.45
Days Gap	-2.04
Depreciation Amortization	405,129
Dollar Volume	2,395
Earnings Date	2026-10-09
EBIT	EUR -37.3M
EBITDA	EUR -36.8M
EPS	EUR -0.71
F Score	2
FCF	EUR -24.9M
FCF EV Yield	-27x
FCF Per Share	EUR -0.53
Financing CF	17,008,673
Fiscal Year End	November
Founded	1,997
Goodwill	6,111,166
Income Tax	EUR 1.5M
Investing CF	630,253
Is Primary Listing	1
Last Earnings Date	2026-07-15
Last Report Date	2026-05-31
Last Split Date	2017-11-07
Last Split Type	Forward
Ma150	2.73
Ma150ch	-8.36%
Ma20	2.51
Ma20ch	-0.48%
Net CF	-8,324,117
Next Earnings Date	2026-10-09
Open	2.4
Position In Range	100
Ppne	195,770
Price Date	2026-09-11
Relative Volume	0.48x
Revenue	7,445,209x
SBC By Revenue	-0.29x
Share Based Comp	-21,715
Tax By Revenue	19.82x
Tr6m	-18.03%
Volume	958
Z Score	-11.4

ETR/HPHA (ETR/HPHA)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/HPHA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/HPHA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/HPHA

Frequently asked questions